1Shimizu E,Nakamura Y,Mukai J,et al.Pharmacokinetics of bronchial artery infusion of mitomycin in patients with non-small cell lung cancer[J].Eur J Cancer,1991,27(8):1046
2Mikaye M, Taki T, Hitomi S, et al. Correlation of expression of H/ Ley / Leb antigens with survival in patients with carcinoma of the lung [J]. N Engl J Med, 1992,327:14- 18.
3Reed JC. Bcl-2 and the regulation of programmed cell death[J]. J Cell Biol, 1994,124:1-5.
4Levine A. The p53 tumor-auppress or gene[J]. N Engl J Med, 1992, 326:1350 - 1352.
5Folkman J. What is the evidence that tumors are angiogenesis dependant? [J]. J Nall Caaeer Inst,1989,82:4-6.
6Hananhan D, Folkman J. Patterns and emerging mechanisms of the angiogenie switch during tumorigenesis[J]. CEU,1996,86:353-364.
7Shimizu E, Na kamura Y, Mukai J, et al. Pharmacokinetics of bronchial artery infusion of mitomycin in patients with non-small cell lung cancer[J].. Eur J Cancer, 1991,27:1046.
8Masuda H, Makita K, Nakajima T. Chest wall implanted reservoir for bronchial arterial infusion of antineoplastie agents in high-aged lung cancer patients[J]. Jpn J Thorae Cardiovasc Surg,1999,47:124.
9Liu ZL. Profess in interventional therapy of lung cancer[ J]. Journal of Postgraduates of Medicine, 2001,24:12.
10Cosano PA, Munoz CL, Rubio SJ, et al. Endoscopic treatment of central airway stenosis: five years experience[J]. Arch Bronconeutool, 2005,41:322.
